Molecular testing company ChromaCode announced the commercial launch of the HDPCR Tick-Borne Pathogen (TBP) Panel, a multiplexPCR test that detects nine of the most common tick-borne pathogens in a single test. The launch marks the company’s first multiplex test using its High Definition Polymerase Chain Reaction (HDPCR) technology. HDPCR multiplexing technology combines proprietary data science algorithms with widely-used, low-cost chemistries to increase the multiplexing levels of common real-time PCR (qPCR) and digital PCR (dPCR) instruments to allow for the simultaneous detection of between five and 50 targets in a single reaction. The TBP panel detects the most common tick-borne pathogens from whole blood specimens in under four hours. Features include a threefold increase in qPCR multiplexing, seamless integration onto common qPCR instrumentation, scalable throughput, and streamlined data analysis, management, and test customization with the ChromaCode Cloud software.